Mom Uses Selfie To Help Break Down Mental Health Stigma

March 2, 2016

When mom Erin Jones posted a selfie with her prescriptions for antidepressants and anti-anxiety medication on Facebook, she inspired a social media movement to help break down the taboo surrounding mental illness. On Sept. 2, Jones — who blogs about being on the Autism spectrum and raising kids with special needs at Mutha Lovin’ Autism – shared […]

Read the full article →

Barriers to Primary Care Physicians Prescribing Buprenorphine

March 2, 2016

Reports on a study of physicians in the State of Washington who participated in a Rural Opioid Addiction Management Project on the use of buprenorphine-naloxone in the treatment of opioid use disorders. Study determined the percentage of physicians who prescribed this treatment, the characteristics associated with the prescribing physicians, the number of patients treated, and […]

Read the full article →

Reversal of central sleep apnoea with change from methadone to buprenorphine-naloxone: a case report

March 2, 2016

Preventing prescription opioid poisoning deaths is a major public health priority in Western societies. Deaths from these medications exceed deaths from all illicit drugs combined [1]. Methadone (for pain treatment) is involved in one third of US prescription opioid overdose deaths despite accounting for only 5% of dispensed opioids [2]. There is a dose-dependent increase […]

Read the full article →

SUBOXONE (Buprenorphine Hydrochloride, Naloxone Hydrochloride) Film, Soluble [Indivior Inc.]

March 2, 2016

Updated Date: Oct 6, 2015 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Read the full article →

Management of opioid-dependent patients: comparison of the cost associated with use of buprenorphine/naloxone or methadone, and their interactions with concomitant treatments for infectious or psychiatric comorbidities.

March 2, 2016

The objective was to estimate the annual interaction management cost of agonist opioid treatment (AOT) for opioid-dependent (OD) patients with buprenorphine-naloxone (Suboxone®) (B/N) or methadone associated with concomitant treatments for infectious (HIV) or psychiatric comorbidities. A costs analysis model was developed to calculate the associated cost of AOT and interaction management. The AOT cost included […]

Read the full article →

Diversion and injection of buprenorphine–naloxone film two years post‐introduction in Australia

March 2, 2016

ConclusionsTwo years post‐introduction, levels of BNX film diversion and injection remained comparable with those for methadone and BNX tablets, and lower than mono‐buprenorphine. We found no evidence that BNX film has lower non‐adherence and diversion than the tablet formulation. [Larance B, Mattick R, Ali R, Lintzeris N, Jenkinson R, White N, Kihas I, Cassidy R, […]

Read the full article →

Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir/Ritonavir (2D Regimen).

March 2, 2016

Authors: Badri PS, Dutta S, Wang H, Podsadecki TJ, Polepally AR, Khatri A, Zha J, Chiu YL, Awni WM, Menon RM Abstract The 2D regimen of ombitasvir and paritaprevir (administered with low-dose ritonavir) is being developed for treatment of genotype subtype 1b and genotypes 2 and 4 chronic hepatitis C virus (HCV) infection. Drug-drug interactions […]

Read the full article →

Opioid Addiction Treatment in the eu5: Market Access Levers for Emerging Brands Entering a Generic Market

March 2, 2016

Standard-of-care for opioid addiction is substitution therapy with methadone, buprenorphine, or buprenorphine/naloxone. As EU5 healthcare budgets tighten, this study explored how emerging brands may gain a foothold in this increasingly generic market, as payers and prescribers balance clinical need with limited funds. (Source: Value in Health)

Read the full article →

Cost-Effectiveness Analysis of Opioid Substitution Treatment in Slovenia

March 2, 2016

We analyzed cost effectiveness of buprenorphine/naloxone combination and sustained release (SR) morphine when compared to methadone in patients treated for opioid dependence in Slovenia. To compare the expected costs of treatment with buprenorphine/naloxone combination and SR morphine, we also performed cost-minimization analysis. (Source: Value in Health)

Read the full article →

The problem with prescription painkillers

March 2, 2016

Pain. It’s a nearly unavoidable part of the human experience. Whether it comes as the result of an injury or accident, surgery, or a health issue such as a headache or infection, arthritis, or fibromyalgia, pain can interfere with the ability to sleep, work, and enjoy life. There are many ways to treat pain. Opioid […]

Read the full article →

← Previous Entries

Next Entries →